Sangamo Therapeutics, Inc. Gains 52.98%
Thu 10 Dec 20 at 05:30 PM
Sangamo Therapeutics, Inc. (SGMO:NASDAQ) jumped higher at $15.65, representing a gain of 53%. On Wed 09 Dec 20, SGMO:NASDAQ hit a New 2-Week High of $10.23. The stock got featured on our News Catalysts scanner on Mon 07 Dec 20 at 09:35 AM in the 'EARNINGS' category. From Wed 25 Nov 20, the stock recorded 55.56% Up Days and 40.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Sangamo Therapeutics, Inc. (SGMO:NASDAQ)
Sangamo Therapeutics Inc is a clinical stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy.
Top 10 Gainers:
- SELLAS Life Sciences Group, Inc. (SLS:NASDAQ), 176.37%
- Immutep Limited (IMMP:NASDAQ), 164.65%
- Veru Inc. (VERU:NASDAQ), 53.47%
- Sangamo Therapeutics, Inc. (SGMO:NASDAQ), 52.98%
- Neos Therapeutics, Inc. (NEOS:NASDAQ), 47.7%
- TG Therapeutics, Inc. (TGTX:NASDAQ), 40.85%
- Arlington Asset Investment Corp. (AI:NYSE), 40.56%
- Peabody Energy Corporation (BTU:NYSE), 37.84%
- ALXO (ALXO:NASDAQ), 37.35%
- Silver Spike Acquisition Corp. (SSPK:NASDAQ), 37.27%